Sign inJoin waitlistJoin the waitlist

AP

Asha Pillai

Associate Professor, Pediatrics · Jackson Memorial Hospital

Credentials: · · · ·

History

Jackson Memorial Hospital
Present

Pediatrics
Stanford University
1995–1998
INDIANA MED COLL, PURDUE UNIV, INDIANAPOLIS
1991–1995

Research

Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
Blood · 2012 · 149 citations
Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease
Blood · 2009 · First of 4 authors · Corresponding · 139 citations
Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation
The Journal of Immunology · 2007 · First of 5 authors · 138 citations

AS
Ashok Srinivasan
7 papers
Brandon Triplett
7 papers
Christine Hartford
7 papers
Mari Dallas
7 papers
Wing-Hang Leung
7 papers
DS
David Shook
5 papers
Joseph Laver
4 papers
SS
Samuel Strober
4 papers
Tracy George
3 papers · 3 as a fellow
Ali Saad
2 papers
Angela Pena
2 papers
Ching-Hon Pui
2 papers

Grants

Novel Innate Mechanisms of Immune Tolerance Induction in Allogeneic Hct for Hemoglobinopathies
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.7M · University of Miami School of Medicine
2018–2022
Novel Innate Mechanisms of Immune Tolerance Induction in Allogeneic Hct for Hemoglobinopathies
National Heart, Lung, and Blood Institute · R56
Contact PI · $445.6K · University of Miami School of Medicine
2015–2018
Regulatory t Cells, Mixed Chimerism: A Novel Transplant Strategy for Thalassemias
National Heart, Lung, and Blood Institute · K08
Contact PI · $653K · St. Jude Children's Research Hospital
2008–2012

Clinical trials

Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies
Principal investigator · Completed · Phase 3
St. Jude Children's Research Hospital
2010–2012